A detailed history of Frazier Financial Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 551 shares of BSX stock, worth $47,870. This represents 0.04% of its overall portfolio holdings.

Number of Shares
551
Previous 630 12.54%
Holding current value
$47,870
Previous $48.5 Million 4.83%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$72.96 - $84.0 $5,763 - $6,636
-79 Reduced 12.54%
551 $46.2 Million
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $4,039 - $4,662
60 Added 10.53%
630 $48.5 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $1,267 - $1,509
22 Added 4.01%
570 $39 Million
Q4 2023

Feb 09, 2024

BUY
$48.64 - $57.81 $26,654 - $31,679
548 New
548 $31.7 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $124B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.